A study about Genekampowermolecule: an inexpensive highly potent antiviral molecule against pandemic coronaviruses (SARS CoV-2) for prevention and treatment options
Description
From Jan, 2020, there is a pandemic outbreak of coronaviruses (SARS CoV-2) going in the world. There is a need of an effective solution for prevention and treatment. In this work, a liquid solution from a plant called Genekampowermolecule was developed, which is applied in oral cavity with a special procedure using buccal swabs during the course of infection in 9 cases and found to cure the corona virus infection fully. The persons taking this molecule as prophylaxis are showing that they donot get the infection, when they are visiting crowded areas like malls and parties in closed room without masks and social distancing now. Even in one case, one fully vaccinated person got full blown infection while she was working with non-vaccinated person, who was taking this molecule and has no infection before, during and after this incident. It was also found that this molecule may be used as preventive measurement also.
Conclusion: Genekampowermolecule may be used for the treatment and prophylaxis of coronavirus infection. Bigger studies are needed to unfold its full potential.
Files
Genekampowermolecule_bearbeitet new.pdf
Files
(335.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:4241deccaa8e5520fcf4a733f481c8ff
|
335.5 kB | Preview Download |
Additional details
References
- Bhatia Sudhir. Pitfalls found in SARS CoV-2 specific test performance during the comparison between WHO recommended method and a commercial test. Atlantic Journal of Medical Science and Research. 2023 (In Press).
- Kyung-Ok Lee, Min-Young Park, Lyoung-Hyo Kim, Hye-Soon Seong, Bo-Hyun Park, and Su-Jin Jeong, Pandemic Novel Influenza A (H1N1) Virus in Korea: The Experience from August to September 2009- Korean J Clin Lab Sci 2009,41:145-152.
- Interim report on pandemic H1N1 influenza virus infections in Korea, August to October, 2009: Abstracts 20th European Congress of Clinical Microbiology and Infectious Diseases: Lee S.H., Park B.H., Kang H.Y., Lee K.O., Kim G.Y.; European Congress of Clinical Microbiology and Infectious Diseases; Vienna, Austria, 10 - 13 April 2010.
- Louca P, Murray B, Klaser K, et al. Modest effects of dietary supplements during the COVID-19 pandemic: insights from 445 850 users of the COVID-19 Symptom Study app. BMJ Nutrition, Prevention & Health 2021;4:e000250. doi:10.1136/ bmjnph-2021-000250.
- Amir Mirzaie, Mehrdad Halaji, Farhad Safarpoor Dehkordi, Reza Ranjbar, Hassan Noorbazargan,A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19), Complementary Therapies in Clinical Practice, Volume 40, 2020, 101214, ISSN 1744-3881, https://doi.org/10.1016/j.ctcp.2020.101214
- -Park, J., Park, R., Jang, M. et al. Coronavirus enzyme inhibitors-experimentally proven natural compounds from plants. J Microbiol. 60, 347–354 (2022). https://doi.org/10.1007/s12275-022-1499-z,